Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of Gilead Sciences, Inc.. A complete text table follows the diagram.
A filing-backed editorial bridge through operating income, using reported figures and explicit reconciliation
Swipe to explore
All displayed amounts are reported filing anchors or arithmetic differences between reported anchors. This refreshed aggregate bridge intentionally does not carry forward company-specific segment claims from the superseded filing.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Operating income | 1 | $10.4B | Reported operating result |
| Income before tax | 2 | $10.3B | Reported pretax result |
| Net non-operating cost | 2 | $140M | Interest and other reconciliation |
| Net income | 3 | $10.5B | Reported bottom line |
| Attribution & other adjustment | 2 | $242M | Bridge to reported net income |
| From | To | Value |
|---|---|---|
| Operating income | Income before tax | $10.3B |
| Operating income | Net non-operating cost | $140M |
| Income before tax | Net income | $10.3B |
| Attribution & other adjustment | Net income | $242M |